Compare ALTO & ACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALTO | ACB |
|---|---|---|
| Founded | 2003 | 2013 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Pharmaceuticals and Biotechnology |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 282.7M | 232.3M |
| IPO Year | 2005 | 2016 |
| Metric | ALTO | ACB |
|---|---|---|
| Price | $3.66 | $5.20 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 4 |
| Target Price | ★ $8.33 | $4.24 |
| AVG Volume (30 Days) | 901.9K | ★ 1.3M |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 119.51 | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $917,927,000.00 | N/A |
| Revenue This Year | $5.33 | N/A |
| Revenue Next Year | $1.09 | $9.38 |
| P/E Ratio | $17.50 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.40 | $2.56 |
| 52 Week High | $6.11 | $6.36 |
| Indicator | ALTO | ACB |
|---|---|---|
| Relative Strength Index (RSI) | 51.93 | 73.32 |
| Support Level | $3.46 | $3.78 |
| Resistance Level | $3.79 | N/A |
| Average True Range (ATR) | 0.15 | 0.18 |
| MACD | 0.02 | 0.13 |
| Stochastic Oscillator | 49.51 | 87.33 |
Alto Ingredients Inc is a producer and distributor of specialty alcohols, renewable fuels and essential ingredients in the United States. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, and Western production.
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.